Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 diseaseJ Schüpbach, H Günthard, M S Fung, et al.Journal of Virology|October 1, 1993
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domainsJ P Moore, Q J Sattentau, H Yoshiyama, et al.Human Antibodies and Hybridomas|January 1, 1994
Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1J G Major, R S Liou, L K Sun, et al.Journal of Virology|February 1, 1992
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120M S Fung, C R Sun, W L Gordon, et al.The Journal of Infectious Diseases|December 1, 1994
A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120H F Günthard, P L Gowland, J Schüpbach, et al.Journal of Virology|August 1, 1993
Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loopJ P Moore, M Thali, B A Jameson, et al.Journal of Virology|September 1, 1989
Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120N C Sun, D D Ho, C R Sun, et al.Virology|December 15, 1996
Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytesP P Jagodzinski, J Wustner, D Kmieciak, et al.Pageof 2